Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery [NA]
Clinical trial is currently recruiting to study neurocognition in patients with brain metastases treated with radiosurgery.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Stereotactic Radiosurgery Dose Escalation for Brain Metastases [Phase 1]
Phase 1 clinical trial evaluating dose-escalation stereotactic radiosurgery for brain metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases [Phase 2]
Phase 2 clinical trial update on Sacituzumab Govitecan in combination with Bevacizumab for non-small cell lung cancer with brain metastases.…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis [NA]
This entry notes a planned clinical trial investigating neoadjuvant stereotactic radiotherapy for brain metastases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors [NA]
Clinical trial update on ExAblate MR-guided focused ultrasound for brain tumors, noting the study is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique [Phase 2]
A Phase 2 clinical trial is recruiting to optimize neurocognition in patients with brain metastases using upfront pulsed reduced dose-rate w…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of UTD1 in combination with Capecitabine for metastatic HER2-negative breast cancer wit…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases [NA]
This clinical trial is recruiting to compare preoperative and postoperative hypofractionated radiosurgery for patients with large brain meta…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases [Phase 2]
A Phase 2 clinical trial is evaluating sacituzumab govitecan in patients with HER2-negative metastatic breast cancer and brain metastases; t…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin [NA]
A prospective double-arm randomized trial compares whole-brain radiotherapy alone versus WBRT plus silibinin in adults with brain metastases…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLC [NA]
Clinical trial update on hippocampus-avoidance whole-brain radiation therapy with simultaneous integrated boost for brain metastases from no…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Radiosurgery Before Surgery for the Treatment of Brain Metastases [EARLY_Phase 1]
This document reports an early-phase clinical trial evaluating radiosurgery before surgery for brain metastases, with the study currently ac…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases [NA]
A clinical trial is planned to evaluate the RayerKnife X Stereotactic Radiotherapy System for treating brain metastases, with recruitment no…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease [Phase 2]
A Phase 2 clinical trial is evaluating GLIADEL wafers versus stereotactic radiosurgery for metastatic brain tumors and is currently recruiti…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain Metastasis [Phase 2]
Phase 2 clinical trial evaluating a PD-L1 monoclonal antibody with VEX metronomic chemotherapy and concurrent or delayed radiotherapy for ad…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal [Phase 2]
Phase 2 clinical trial evaluating stereotactic radiotherapy for hemorrhagic brain metastases is currently recruiting, sponsored by Centre Fr…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating SHR-A1811 with Pyrotinib and Bevacizumab for advanced breast cancer with brain metastases. The stud…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases [NA]
This clinical trial update describes a study using advanced diffusion MRI to differentiate tumor recurrence from pseudoprogression in gliobl…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer [Phase 2]
A Phase 2 trial from Fudan University is exploring heterogeneity in 68Ga-FAPI uptake as an imaging biomarker for brain metastases in HER2-po…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC [Phase 2]
Phase 2 clinical trial update for IvoneScimab in combination with a Trop2-targeted antibody-drug conjugate for brain metastases in patients …
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC [NA]
This clinical trial compares MRI screening to symptom-directed surveillance for brain metastases in patients with triple-negative or HER2-po…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Cryoablation of Brain Neoplasm [NA]
An Erasmus Medical Center-sponsored clinical trial is evaluating cryoablation for brain neoplasms, currently enrolling by invitation. The co…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study [Phase 2]
Phase II single-arm study evaluating furmonertinib plus bevacizumab as first-line therapy for EGFR-mutant non-small cell lung cancer with br…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Measuring and Mapping Cognitive Decline After Brain Radiosurgery
A University of Nottingham-led clinical trial is recruiting to measure and map cognitive decline after brain radiosurgery in patients with b…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
Monash University is conducting a study on routine screening and molecular characterization of brain metastases to guide management of high-…